Please login to the form below

Not currently logged in
Email:
Password:

Euthyrox

This page shows the latest Euthyrox news and features for those working in and with pharma, biotech and healthcare.

Merck KGaA to make $3m payout to patients after drug formulation complaints

Merck KGaA to make $3m payout to patients after drug formulation complaints

When former health minister Agnès Buzyn made the original formula, Euthyrox, available after a public outcry, half of the 130, 000 boxes that were put back on pharmacy shelves sold out

Latest news

  • Merck Serono to invest €150m in China R&D

    The Swiss-based company's key products Erbitux (cancer), Rebif (multiple sclerosis), Gobal-f (infertility), Saizen (endocrine and metabolic disorders) and Concor and Euthyrox (cardiometabolic diseases) are already available in the

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...